Catheter ablation for atrial fibrillation in HFpEF patients-A propensity-score-matched analysis.
Manuel RattkaAnna KühbergerAlexander PottTilman StephanKarolina Weinmann-EmhardtMichael BaumhardtDeniz AktolgaYannick TeumerCarlo BothnerDominik ScharnbeckWolfgang RottbauerTillman DahmePublished in: Journal of cardiovascular electrophysiology (2021)
Catheter ablation for AF in HFpEF patients in comparison to medical therapy decreases heart failure hospitalization, heart failure symptoms, and improves diastolic function. AF ablation should be considered in patients with HFpEF and concomitant AF.
Keyphrases
- atrial fibrillation
- catheter ablation
- heart failure
- left atrial
- left atrial appendage
- end stage renal disease
- oral anticoagulants
- ejection fraction
- direct oral anticoagulants
- newly diagnosed
- chronic kidney disease
- prognostic factors
- left ventricular
- percutaneous coronary intervention
- patient reported outcomes
- peritoneal dialysis
- bone marrow
- mesenchymal stem cells
- acute coronary syndrome
- cardiac resynchronization therapy